Although CAR-T therapy demonstrated huge possiblity for the treatment of cancers with high efficiency, compelling challenges still exist regarding the feasibility of this therapy for severe immune deficiency and other cytotoxicity caused by its "on-target, off-tumor" effect [172, 173]
Product Specifications Product Name: BPC-157 Category: Synthetic pentadecapeptide (15 amino acids) Research Classification: Investigational peptide for laboratory research Molecular Formula: CHNO Molecular Weight: Approximately 1419.5 g/mol Peptide Length: 15 amino acids Purity: 9598% (HPLC verified) Appearance: White to off-white lyophilized powder Storage (Lyophilized): 20C to 80C, protected from moisture and light Storage (Reconstituted): 4C for short-term laboratory use Compliance: Not approved by FDA or EMA
Vasculitis: Vasculitis is inflammation of the blood vessels, which increases the risk of clots and blockages
Zhao B, Hemann MT, Lauffenburger DA (2014a) Intratumor heterogeneity alters most effective drugs in designed combinations
Wang X, Gong W, Xiong X, Jia X,Xu J, Asparagine
